Sectors

SXTC
China SXT Pharmaceuticals, Inc.
2.55
2 x 2.50
3 x 2.68
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd-98.94%
1y-98.98%
2.48
day range
2.55
1.25
52 week range
1047.00
Open2.52Prev Close2.55Low2.48High2.55Mkt Cap1.73M
Vol3.97KAvg Vol66.83KEPS2.80P/E0.91Forward P/EN/A
Beta1.82Short Ratio0.52Inst. Own1.35%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg1.97200-d Avg85.311yr Est0.00
Upgrade / Downgrade
DateFirmActionFromTo
Profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Baader Bank Aktiengesellschaft15.16K5.26K0.37%
2024-09-29Gsa Capital Partners Llp12.30K4.26K0.30%
2024-09-29Bank of Montreal /CAN/10.00K3.47K0.25%
2024-09-29UBS Group AG8.68K3.01K0.21%
2024-09-29JP Morgan Chase & Company376.00130.000.01%
2024-09-29Acadian Asset Management. LLC379.00131.000.01%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2023-10-30Fidelity NASDAQ Composite Index Fund54.0018.000.00%
Split
SplitDate
1 : 1502026-02-03
1 : 82025-02-25
1 : 252023-10-05
1 : 202022-05-19
1 : 42021-02-22